Literature DB >> 16142861

Prevalence of rheumatoid arthritis in the South-Transdanubian region of Hungary based on a representative survey of 10,000 inhabitants.

Csaba G Kiss1, Csilla Lövei, Gábor Sütö, Cecília Varjú, Zoltán Nagy, Zsuzsanna Füzesi, Tamás Illés, László Czirják.   

Abstract

OBJECTIVE: To assess the prevalence of rheumatoid arthritis (RA) in a representative study of the South Transdanubian region of Hungary.
METHODS: Ten thousand individuals aged between 14-65 years were interviewed. The stratified sample was representative for age, sex and urban/rural residence structure of the regional population of the South-West Hungarian region. As a second step, all individuals with possible RA were asked to undergo a clinical investigation to confirm the diagnosis of RA according to the American Rheumatism Association (ARA) 1987 criteria. Of 10,000 interviewed individuals, 632 reported having RA or symptoms including digital pain, stiffness, and/or swelling. Two hundred and twenty-four individuals were investigated clinically. Individuals fulfilling the 1987 ARA criteria were considered as having definite RA, and their clinical data were evaluated.
RESULTS: RA was confirmed in 13 cases. The male/female ratio was 3/10. The prevalence of RA among individuals aged 14-65 years was 0.37% (95% confidence interval, CI: 0.26-0.51), 0.23% (95% CI: 0.15-0.35) in men and 0.48% (95% CI: 0.35-0.64) in women.
CONCLUSION: The prevalence of RA in the South Transdanubian region of Hungary is similar to those of other recent studies from other regions around the world.

Entities:  

Mesh:

Year:  2005        PMID: 16142861

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  10 in total

1.  The time for cost-effectiveness in the new European Union member states: the development and role of health economics and technology assessment in the mirror of the Hungarian experience.

Authors:  László Gulácsi
Journal:  Eur J Health Econ       Date:  2007-06

2.  The burden of disease in rheumatoid arthritis.

Authors:  Till Uhlig; Rikke H Moe; Tore K Kvien
Journal:  Pharmacoeconomics       Date:  2014-09       Impact factor: 4.981

Review 3.  Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries.

Authors:  Márta Péntek; Gyula Poór; Piotr Wiland; Martina Olejárová; Marek Brzosko; Catalin Codreanu; Nóra Brodszky; László Gulácsi
Journal:  Eur J Health Econ       Date:  2014-05-16

Review 4.  Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications.

Authors:  Lili Magyari; Dalma Varszegi; Erzsebet Kovesdi; Patricia Sarlos; Bernadett Farago; Andras Javorhazy; Katalin Sumegi; Zsolt Banfai; Bela Melegh
Journal:  World J Orthop       Date:  2014-09-18

5.  Prevalence of rheumatoid arthritis in Serbia.

Authors:  Mirjana I Zlatković-Švenda; Roksanda M Stojanović; Sandra B Šipetić-Grujičić; Francis Guillemin
Journal:  Rheumatol Int       Date:  2013-11-29       Impact factor: 2.631

Review 6.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases.

Authors:  Glinda S Cooper; Milele L K Bynum; Emily C Somers
Journal:  J Autoimmun       Date:  2009-10-09       Impact factor: 7.094

7.  Serum Copper as a Marker of Disease Activity in Rheumatoid Arthritis.

Authors:  Montosh Chakraborty; Happy Chutia; Rita Changkakati
Journal:  J Clin Diagn Res       Date:  2015-12-01

8.  Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries.

Authors:  Ewa Orlewska; Ioan Ancuta; Branimir Anic; Catalin Codrenau; Nemanja Damjanov; Predrag Djukic; Ruxandra Ionescu; Lubomir Marinchev; Evgeny L Nasonov; Tonu Peets; Sonja Praprotnik; Rasho Rashkov; Jana Skoupa; Witold Tlustochowicz; Malgorzata Tlustochowicz; Matija Tomsic; Tiina Veldi; Jelena Vojinovic; Piotr Wiland
Journal:  Med Sci Monit       Date:  2011-04

9.  Prevalence of rheumatoid arthritis in the southern part of denmark.

Authors:  Jens K Pedersen; Anders J Svendsen; Kim Hørslev-Petersen
Journal:  Open Rheumatol J       Date:  2011-12-02

10.  Quality of Life and Cost Study of Rheumatoid Arthritis Therapy With Biological Medicines.

Authors:  Vladimira V Boyadzieva; Nikolay Stoilov; Rumen M Stoilov; Konstantin Tachkov; Maria Kamusheva; Konstantin Mitov; Guenka I Petrova
Journal:  Front Pharmacol       Date:  2018-07-18       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.